SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-17-003359
Filing Date
2017-04-05
Accepted
2017-04-05 09:29:02
Documents
2
Period of Report
2017-04-05

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k040517_therapixbio.htm 6-K 18620
2 PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON APRIL 5, 2017, ANNOUNCING I f6k040517ex99i_therapixbio.htm EX-99.1 9385
  Complete submission text file 0001213900-17-003359.txt   29058
Mailing Address SCIENCE PARK, 18 EINSTIEN ST. P.O BOX 4122 NESS-ZIONA L3 7414002
Business Address SCIENCE PARK, 18 EINSTIEN ST. P.O BOX 4122 NESS-ZIONA L3 7414002 972-8-9396577
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 17741268
SIC: 2834 Pharmaceutical Preparations